MarketPeel
Insider Trading Intelligence
Pricing
…
CH

Cyrus Harmon

OLMA
CHIEF TECHNOLOGY OFFICER · OLEMA PHARMACEUTICALS, INC. · CIK 0001831410
FILING MIX · LIFETIME20%/80%
BUYS
13
SELLS
51
TOTAL VALUE
$6.23M
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
29,500
AVG SELL PX
$13.65
TRADE KIND
SHOWING 64 / 64
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
48 backtested trades · 8 horizons · 22 pending
Forward-return performance of every backtestable P/S trade by Cyrus Harmon, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d48+47.92%+2.33%+0.61%+1.73%-0.98%0.63
14d48+47.92%+1.24%+1.68%-0.44%-2.55%-0.16
30d48+47.92%-0.39%+1.90%-2.29%-4.08%-0.71
60d48+52.08%-5.24%+3.31%-8.54%-8.71%-2.07
90d48+52.08%+21.48%+4.50%+16.98%-9.39%1.19
180d48(2 pending)+65.22%-11.26%+9.72%-20.98%-44.19%-2.25
1y48(7 pending)+80.49%-19.66%+14.13%-33.78%-73.73%-2.37
2y48(13 pending)+57.14%-1.38%+33.07%-35.91%-58.49%-3.75
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
OLMA · 29,500 shares · as of Jun 18, 2026
0277,887555,773833,6601,111,546202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 13 buys / 51 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
29,500——29,500Jun 18, 2026Jun 23, 2026 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
10,000$26.88$268.8K727,770Jan 20, 2026Jan 21, 2026 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
3,489$29.12$101.6K737,770Jan 14, 2026Jan 16, 2026 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
2,881$28.53$82.2K741,259Dec 22, 2025Dec 29, 2025 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
3,086$8.32$25.7K117,028Sep 18, 2025Sep 18, 2025 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
10,000$8.33$83.3K744,140Sep 18, 2025Sep 18, 2025 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
10,000$8.04$80.4K754,140Sep 16, 2025Sep 18, 2025 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
1,914$8.08$15.5K120,114Sep 16, 2025Sep 18, 2025 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
24,150——24,150Jun 11, 2025Jun 13, 2025 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
7,958$8.66$68.9K764,319Dec 11, 2024Dec 11, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
179$9.39$1.7K764,140Dec 11, 2024Dec 11, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
8,256$9.37$77.4K772,277Dec 10, 2024Dec 11, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
29,250——780,533Dec 9, 2024Dec 11, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
934$15.55$14.5K751,283Jul 30, 2024Jul 31, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
4,066$15.58$63.3K752,217Jul 29, 2024Jul 31, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
5,000$12.26$61.3K756,283Jul 11, 2024Jul 12, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
20,000$10.77$215.4K761,283Jun 28, 2024Jul 2, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
23,000——23,000Jun 14, 2024Jun 18, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
5,000$12.33$61.6K781,283Jun 4, 2024Jun 4, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
5,000$10.93$54.6K786,283Jun 3, 2024Jun 4, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
15,000$9.41$141.2K791,283May 31, 2024Jun 4, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
5,000$10.92$54.6K806,283May 6, 2024May 7, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
15,000$9.51$142.7K811,283Apr 30, 2024May 2, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
20,000$10.97$219.4K826,283Mar 28, 2024Mar 29, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
100$13.00$1.3K846,283Feb 29, 2024Mar 4, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
24,900$12.41$309.0K846,383Feb 29, 2024Mar 4, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
5,000$15.56$77.8K871,283Feb 1, 2024Feb 2, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
25,000$12.23$305.8K876,283Jan 31, 2024Feb 2, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
2,500$14.10$35.3K901,283Dec 29, 2023Jan 2, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
22,500$13.30$299.3K903,783Dec 29, 2023Jan 2, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
25,000$12.57$314.3K926,283Nov 30, 2023Dec 1, 2023 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
3,989$13.90$55.4K951,283Nov 22, 2023Nov 22, 2023 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
4,192$14.86$62.3K955,272Nov 21, 2023Nov 22, 2023 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
15,750——959,464Nov 20, 2023Nov 22, 2023 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
5,000$15.64$78.2K943,714Nov 2, 2023Nov 2, 2023 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
25,000$12.05$301.3K948,714Oct 31, 2023Nov 2, 2023 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
25,000$12.41$310.3K973,714Sep 29, 2023Oct 3, 2023 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
10,000$11.62$116.2K998,714Sep 5, 2023Sep 5, 2023 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
15,000$9.36$140.4K1,008,714Aug 31, 2023Sep 5, 2023 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
15,000$10.14$152.1K1,023,714Aug 16, 2023Sep 5, 2023 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
15,000$10.14$152.1K1,023,714Aug 16, 2023Aug 17, 2023 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
10,000$6.30$63.0K1,038,714Jun 8, 2023Jun 9, 2023 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
5,000$6.30$31.5K1,048,714Jun 6, 2023Jun 7, 2023 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
5,000$6.05$30.2K1,053,714Jun 5, 2023Jun 7, 2023 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
150,000——150,000Feb 1, 2023Feb 2, 2023 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
104,500——104,500Feb 1, 2022Feb 3, 2022 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
CHIEF TECHNOLOGY OFFICER
400$24.76$9.9K1,051,146Nov 29, 2021Dec 1, 2021 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
CHIEF TECHNOLOGY OFFICER
7,445$27.85$207.3K1,056,101Oct 19, 2021Oct 20, 2021 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
CHIEF TECHNOLOGY OFFICER
4,555$28.20$128.5K1,051,546Oct 19, 2021Oct 20, 2021 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
CHIEF TECHNOLOGY OFFICER
12,000$26.30$315.6K1,063,546Sep 20, 2021Sep 21, 2021 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
CHIEF TECHNOLOGY OFFICER
12,000$24.97$299.6K1,075,546Aug 19, 2021Aug 20, 2021 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
CHIEF TECHNOLOGY OFFICER
4,123$25.63$105.7K1,087,546Jul 20, 2021Jul 21, 2021 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
CHIEF TECHNOLOGY OFFICER
7,877$24.83$195.6K1,091,669Jul 19, 2021Jul 21, 2021 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
CHIEF TECHNOLOGY OFFICER
1,990$25.59$50.9K1,100,146Jun 18, 2021Jun 21, 2021 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
CHIEF TECHNOLOGY OFFICER
600$26.30$15.8K1,099,546Jun 18, 2021Jun 21, 2021 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
CHIEF TECHNOLOGY OFFICER
9,410$24.54$230.9K1,102,136Jun 18, 2021Jun 21, 2021 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
Chief Technology Officer
122,028——122,028Nov 23, 2020Nov 23, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
Chief Technology Officer
122,028——0Nov 23, 2020Nov 23, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
Chief Technology Officer
71,374——0Nov 23, 2020Nov 23, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
Chief Technology Officer
71,374——1,111,546Nov 23, 2020Nov 23, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,076——1,076Nov 18, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
179,340——179,340Nov 18, 2020Nov 19, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
227,859——227,859Sep 12, 2020Nov 19, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
143,472——1,040,172Jun 15, 2020Nov 19, 2020 ↗View →
Other insiders · OLMA
Loading peer insiders…
About this filer
CIK 0001831410
ROLE
CHIEF TECHNOLOGY OFFICER
PRIMARY
OLMA
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001831410DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback